(02) 9926 4726

News and Event

Sydney Cancer Conference 2018 – Closed

This will be the sixth Sydney Cancer Conference and is focusing on the theme of ‘Bridging research and practice,’ the program features all areas of cancer research – basic biomedical, public health, clinical and psychosocial – making the latest information and research available to delegates.

Sydney vital will be supporting up to ten attendees and applications are invited from suitably qualified researchers. Our aim is to encourage outstanding PhD students, ECRs, researchers and clinicians from within the Sydney Vital network and institutions to present their scientific research progress at national or international conferences.

Submission Guidelines

Applications must complete the Sydney Vital Registration Support Form for the SCC2018 and must be submitted as a single PDF attachment in an email to [email protected]. Please use the following naming convention:

LastName_FirstName_SCC2018

Once approved, Sydney Vital will complete payment of the successful applicants’ registration fee. Please note, we will not reimburse any payments that have been made prior to applying for registration support.

Applications will close on Friday 25th May 2018. Sydney Vital Centre Manager, Suzie Nguyen, can be contacted on 9926 4726 or at [email protected] to assist with any queries.

Read more

Research Fellowship in the area of Nanotechnology – Closed

Applications are invited from suitably qualified researchers for a Research Fellowship under Sydney Vital Flagship Program 3: Nanotechnology.

This is also to invite any of you interested in Translational Cancer Research to become a member of Sydney Vital.

Key Dates

Closing Date for Applications: Friday 13th April 2018.

Please read on: Flagship 3_ Nanotechnology_Research Fellowship_ Guidelines_2018

Please let us know if you have any further questions.

Email: [email protected] for general information regarding your application submission.

Email: Alexander Engel: [email protected] for specific question regarding the Flagship 3.

Read more

Research Fellowship in the area of Nanotechnology – CLOSED

Applications are invited from suitably qualified researchers for a Research Fellowship under Sydney Vital Flagship Program 3: Nanotechnology.

This is also to invite any of you interested in Translational Cancer Research to become a member of Sydney Vital.

Key Dates

Call for Applications: Tuesday 31st January 2017
Closing Date for Applications: Tuesday 27th February 2017
Announcement of Outcome aim at: Wednesday 15th March 2017
Please read on: Flagship3_ Nanotechnology_Research Fellowship_ Application_2017-31012017

Please let us know if you have any further questions.

Email: [email protected] for general information regarding your application submission.

Email: Alexander Engel: [email protected] for specific question regarding the Flagship 3.

Read more

Funding Awarded By Sydney Vital

The research projects below were awarded by Sydney Vital. We will post their progress when it is submitted and to keep up-to-date with our scholarships, funding and awards, check out our grant schemes.

#AwardeeInstitutionSupervisorResearch TitleAmount
Awarded
1Jerikho BulanadiKolling Institute of Medical ResearchProf Ross SmithChemotherapeutic prodrugs incorporated within recombinant high density lipoprotein nanoparticles as a modality of targeted delivery.$15,000
2Emma ColvillSydney University Medical SchoolProf Paul KeallThe bench-to-bedside clinical implementation of real-time targeted radiotherapy for prostate cancer$15,000
3Grace GiffordHaematology and Anatomical Pathology Departments. Royal North Shore Hospital, St Leonards, SydneyDr William StevensonGene expression profiling of high grade B-cell lymphomas with NanoString nCounter technology. Validation of a novel diagnostic platform and implementation into clinical use for prognostication and therapeutic decision-making.$15,000
4Dr Anthony GloverKolling Institute of Medical Research, Royal North Shore HospitalProf Stanley SidhuNoncoding RNAs as tumour suppressors in adrenal cancer: Unlocking the mechanisms to improve patient outcomes.$15,000
5Diana HatoumFaculty of Science, UTS SydneyDr Najah NassifA Role for p14ARF-p53 in Treatment Resistance and Recurrence in Hormone-dependent Breast Cancer.$15,000
6Samuel BrennanFaculty of Science, UTS SydneyDr Rose Martiniello-WilksDevelopment of a non-invasive liquid biopsy for prostate cancer: Identification of unique exosome microRNA (exomiR) signatures in patient body fluids for cancer diagnosis and prognosis.$15,000
7Ben HarrisSydney Medical School, University of SydneyDr Kellie CharlesInvestigating mechanisms of chemoresistance to platinum drugs mediated by systemic inflammation.
$15,000
8Adrian LeeBill Walsh Translation Cancer Research Laboratory, Kolling InstituteDr Viive Howell"Do molecular aberrations in the tumour predict for venous thrombotic episodes in patients with
glioblastoma multiforme?"
$15,000
9Jaynish ShahSydney Medical School, University of SydneyProf Deborah MarshInvestigating the complexity of p53 pathways in ovarian cancer: are non-coding RNAs the key?$15,000
Read more

Research Scholarship Awards Round 3 – CLOSED

Sydney Vital is pleased to offer 5 x Research Scholarship Awards to the value of $15,000 each for one year to students, preclinical and clinical researchers working in the area of Translational Cancer Research. These awards are to be used to support the research and are to be spent at the discretion of the student and their supervisor(s).

Key Dates for Round 3

Call for Applications: 1 September 2015

Closing Date for Applications: 1 October 2015

Announcement of Outcome: 1 November 2015

Sydney Vital_Research Scholar Award_Guidelines_Round 3_2015

Sydney Vital Research Scholarship_General Feedback_Round 2

Other Grant Opportunities

Read more

Implementation Research Pilot projects – CLOSED

CALL FOR EOI’S

Sydney Vital is calling for proposals for implementation research pilot projects via an Expression of Interests (EOI) process.
Sydney Vital will provide financial support for a number of implementation research projects in the 2015 calendar year.

This expression of interest (EOI) may include (but are not limited to) the following themes:
• Educate Sydney Vital member network on implementation (T3) of evidence based supportive care strategies for cancer symptoms and treatment side effects.
• Develop Health Professional Education modules using e-learning techniques which can be made available to clinicians in NSW.
• Identify new clinical pathways or techniques based on the evidence based guidelines suitable for implementation
• Test methods for delivery of psychosocial support and reduction of treatment toxicity
• Evaluating new approaches to breast reconstruction and their impact on Quality of Life (QoL).
• Identify ways to improve management of survivorship issues in cancer patients.
• Test new methods of care or prognostic factors for patients with late stage cancer.

FUNDING AVAILABLE
Up to $25,000 in funding to support the undertaking of an implementation research project. The funding must be spent within 12 months of receiving the award. Management team may allocate funding to one or more projects.

Read More: Implementation Research_Seed Funding 2015_EOI
Closing Date for EOI’s: Friday, 5 June 2015

Read more

Supportive care, end stage tumour, and end-of life management – CLOSED

CALL FOR EOI’S FOR PILLAR LEADERS

Sydney Vital is seeking 2 individuals to act as leader for Pillar 4:
“Supportive care, end stage tumours, and end-of life management”. The Pillar’s aims are deliberately broad to allow scope to explore and exploit strengths within the partner organisations. The Pillar provides base funding of $10 k p.a. (which can be further leveraged) to support activities to bring Pillar members together to develop new programs of research, both basic science and clinical, and to expand networks and collaborations. Ideally, the Pillars would have outputs that impact on the T1, T2 and T3 domains of translational research as defined by the CINSW, or the Sydney Vital Flagship Programs 1, 2, or 3 (www.sydneyvital.org.com). The Pillar leader is ideally an early to mid-career researcher who is currently developing their research portfolio.

Read More: Pillar 4 EOI_ 2015
Closing Date for EOI’s: Friday, 5th June 2015

Read more

Flagship 1 Seed Funding – CLOSED

The Sydney Vital Flagship 1 program has up to $25,000 available to encourage the development of new research ideas in preclinical studies of treatment-resistant cancers. Projects should concern
(i) new therapies for treatment-resistant cancers, or
(ii) the identification of new biomarkers of treatment resistance.

Applications are sought from Sydney Vital members for two 1-year grants of up to $12,000 each in either of the above areas. Each applicant may submit only one application in this funding round. These grants are not intended to support the extension or expansion of existing research projects, but are to seed new ideas, with the goal of generating data to a point where external funding may be sought.

Read More: Sydney Vital Flagship 1 SEED FUNDING

Closing date: Sunday, 17th May 2015

Read more

Postgraduate Scholarship – Closed

microRNA Translational Research

Funding Body:
The Kolling Institute of Medical Research

Funding Source:
Sydney Medical School Foundation

Description:
The Kolling Institute of Medical Research is the principal centre of health and medical research affiliated with the Northern Sydney Local Health District. As a centre of research excellence the Kolling has a major role in research training through the Sydney Medical School (Northern Clinical School) of the University of Sydney.

The Cancer Genetics Adrenal Laboratory studies neoplasms of the adrenal cortex (adrenocortical tumours) and of the adrenal medulla (phaeochromocytomas). Overall the work focuses on discovering markers to assist with the early identification of malignancy, and finding genes which will lead to a greater understanding of the pathogenesis of adrenal tumours and thereby ultimately improving the clinical management of these patients and their families. Adrenocortical cancer (ACC) is an aggressive malignancy with limited treatment options. Recent studies have shown that a number of microRNAs are down-regulated in ACC, indicating their potential as a tumour suppressor gene and therapeutic target.

We are pleased to offer a PhD scholarship to a skilled and motivated PhD candidate to join our translational research team headed by Professor Stan Sidhu. We are seeking applications from outstanding medical science/biology graduates who are interested in pursuing a career in translation medical research, in particular cancer research. The role involves an interdisciplinary research project elucidating the mechanism of microRNA as a tumour suppressor gene and potential therapeutic target in ACC. This project will provide an opportunity to gain experience in cancer genetics, cell biology and cancer translational research.

The successful full-time candidates will be supervised by Dr Jing Ting Zhao and Professor Stan Sidhu and. The position is located in the Cancer Genetics Group of the Kolling Institute of Medical Research, Royal North Shore Hospital, St Leonard, NSW, 2065.

Eligibility:
The successful candidate will have:

  • Bachelor of Medical Science/Biology with Class I Honours or equivalent
  • Demonstrated commitment to quality and detailed research experiments and analysis of results.
  • Strong communication skills and the ability to work as a part of team
  • Australian citizenship or permanent residency

Amount awarded:
$25,392 per annum (tax exempt), up to 3 years. The stipend rate is indexed annually on 1st January.

Application guide:
To submit an application for this position please email directly to Dr Jing Ting Zhao at [email protected].

  • Applications should include a cover letter with a brief research statement addressing the above criteria, a current CV including names of two referees and a copy of your Academic Transcripts.
  • All enquiries are forwarded to Dr Jing Ting Zhao on the email above or (02) 9926 4769.

Students with an interest in cancer genetics, endocrinology and related fields of translational medicine are encouraged to apply.

Closing date:
10th October 2014

Read more